Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction‐Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective.
Saved in:
| Title: | Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction‐Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective. |
|---|---|
| Authors: | Younossi, Zobair M.1,2 (AUTHOR) zobair.younossi@cldq.org, Razavi, Homie3 (AUTHOR), Sherman, Michael4,5 (AUTHOR), Allen, Alina M.6 (AUTHOR), Anstee, Quentin M.7,8 (AUTHOR), Cusi, Kenneth9 (AUTHOR), Friedman, Scott L.10 (AUTHOR), Lawitz, Eric11 (AUTHOR), Lazarus, Jeffrey V.12,13,14 (AUTHOR), Schuppan, Detlef15,16 (AUTHOR), Romero‐Gómez, Manuel17 (AUTHOR), Schattenberg, Jörn M.18 (AUTHOR), Vos, Miriam B.19 (AUTHOR), Wong, Vincent Wai‐Sun20 (AUTHOR), Ratziu, Vlad21 (AUTHOR), Hompesch, Marcus22 (AUTHOR), Sanyal, Arun J.23 (AUTHOR), Loomba, Rohit24 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. May2025, Vol. 61 Issue 9, p1467-1478. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
